Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
February 17, 2021 at 04:34 am
Share
DGAP Preliminary announcement financial reports: Merck KGaA
/ Preliminary announcement on the disclosure of financial statements
Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
17.02.2021 / 10:32
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Merck KGaA hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report
Language: German
Date of disclosure: March 04, 2021
Address: https://www.merckgroup.com/de/investors/reports-and-financials.html
Language: English
Date of disclosure: March 04, 2021
Address: https://www.merckgroup.com/en/investors/reports-and-financials.html
Report Type: Annual financial report of the group
Language: German
Date of disclosure: March 04, 2021
Address: https://www.merckgroup.com/de/investors/reports-and-financials.html
Language: English
Date of disclosure: March 04, 2021
Address: https://www.merckgroup.com/en/investors/reports-and-financials.html
Report Type: Financial report of the group (half-year/Q2)
Language: German
Date of disclosure: August 05, 2021
Address: https://www.merckgroup.com/de/investors/reports-and-financials.html
Language: English
Date of disclosure: August 05, 2021
Address: https://www.merckgroup.com/en/investors/reports-and-financials.html
17.02.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- solutions and products for scientific and biotechnological research (44.2%);
- pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc.
Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]